期刊文献+

血浆脑钠肽水平与急性冠状动脉综合征患者心血管事件的相关性研究 被引量:8

Relationship between plasma BNP levels and major adverse cardiovascular events in ACS patients
下载PDF
导出
摘要 目的探讨血浆脑钠肽(BNP)与急性冠状动脉综合征(ACS)患者发生主要不良心血管事件(MACE)的相关性。方法收集该院就诊的ACS患者210例,检查住院期间的BNP,并记录住院期间和出院后30dMACE的发生情况。根据BNP的不同,把ACS患者分成两组(A组:BNP<100pg/mL;B组:BNP≥100pg/mL),比较两组患者发生MACE的差异。结果 B组患者的平均年龄为(65.9±11.4)岁,明显高于A组的(62.6±10.3)岁(P=0.03);B组ST段抬高型心肌梗死患者占53.7%,高于A组的34.3%(P=0.005);两组患者在性别、糖尿病、高血压、血脂异常和吸烟史等方面差异无统计学意义(P>0.05)。住院期间,B组MACE的发生率为17.6%,明显高于A组的4.9%(P=0.004);B组心因性病死率和再发心肌梗死率均明显高于A组(P<0.05)。入院至出院后1个月,B组MACE的发生率为33.3%,明显高于A组的9.8%(P<0.01);B组心因性病死率、再发心肌梗死率和再次血运重建率均明显高于A组(P<0.05)。结论血浆BNP水平的增高,增加ACS患者短期MACE的发生率。临床上对BNP>100pg/mL的ACS患者应给予更多的关注。 Objective To investigate the relationship between brain natriuretic peptide (BNP) and major ad-verse cardiovascular events(MACE) in acute coronary syndrome(ACS) patients .Methods Two hundred and ten ACS patients ,treated in this hospital ,were enrolled .Plasma BNP was detected ,and MACE during hospitalization and within 30 days after discharging were collected .According to plasma BNP level ,all patients were divided into group A ,with BNP〈100 pg/mL ,and group B ,with BNP≥100 pg/mL .MACE were compared between the two groups .Re-sults The mean age of group B was (65 .9 ± 11 .4)years ,which was significantly higher than the (62 .6 ± 10 .3)years of group A(P=0 .03) .The proportion of patients with ST segment elevation myocardial infarction (STEMI) in group B was 53 .7% ,which was significantly higher than the 34 .3% in group A(P=0 .005) .However ,the differences of sex ,diabetes ,hypertension ,dyslipidemia and smoking were not statistically significant (P〉0 .05) .During hospitaliza-tion ,incidence rate of MACE in group B was 17 .6% ,which was higher than the 4 .9% of group A(P=0 .004) ,and cardiac mortality and recurrence of myocardial infarction in group B were also higher than group A (P〈0 .05) .One-month after discharging ,incidence rate of MACE in group B was 33 .3% ,which was higher than the 9 .8% in group A(P〈0 .01) ,and cardiac mortality ,recurrence of myocardial infarction and re-revascularization of group B were also higher than group A(P〈0 .05) .Conclusion Incidence rate of short-term MACE might be increased in ACS patients with the increasing of plasma BNP levels .To ACS patients with BNP≥100 pg/mL ,more attention should be paid in clinical works .
作者 黄涛 李奇俊
出处 《检验医学与临床》 CAS 2014年第9期1210-1212,共3页 Laboratory Medicine and Clinic
关键词 脑钠肽 急性冠状动脉综合征 主要心血管不良事件 brain natriuretic peptide acute coronary syndrome major adverse cardiovascular events
  • 相关文献

参考文献14

  • 1Harem CW,Bassand JP, Agewall S, et al. ESC guidelines for the management of acute coronary syndromes in pa- tients presenting without persistent ST-segment eleva- tion: the task force/or the management of acute coronary syndromes(ACS)in patients presenting without persistent ST-segment elevation of the European society of cardiolo- gy(ESC)[J]. Eur Heart J,2011,32(23) :2999-3054.
  • 2Sudoh T, Kangawa K, Minamino N, et al. A new natri- uretic peptide in porcine brain [J]. Nature, 1988, 332 (6159) :78-81.
  • 3Gobinet-Georges A, Valli N, Filliatre H, et al. Stability of brain natriuretic peptide(BNP) in human whole blood and plasmarJ. Clin Chem Lab Med,2000,38(6) :519-523.
  • 4Kroon MH,van den Hurk K,Alssema M,et al. Prospec- tive associations of B-type natriuretic peptide with mark- ers of left ventricular function in individuals with and without type 2 diabetes., an 8-year follow-up of the Hoorn Study[J]. Diabetes Care,2012,35(12) :2510-2514.
  • 5Goto T, Takase H, Toriyama T, et al. Circulating concen- trations of cardiac proteins indicate the severity of conges- tive heart failure[J]. Heart,2003,89(11),1303-1307.
  • 6Francis CK, Kuo YH, Azzam I, et al. Brain natriuretic peptide and biomarkers of myocardial ischemia increase after defibrillation threshold testing[J]. Pacing Clin Elec- trophysiol,2012,35 (3) :314-319.
  • 7Morrow DA, de Lemos JA, Sabatine MS, et al. Evaluation of B-type natriuretie peptide for risk assessment in unsta- ble angina/non-ST-elevation myocardial infarction: B-type natriuretic peptide and prognosis in TACTICS-TIMI 18 [J]. J Am Coll Cardiol,2003,41(8) : 1264-1272.
  • 8Morice MC, Serruys PW, Kappetein AP, et al. Outcomes in patients with de novo left main disease treated with ei- ther pereutaneous coronary intervention using paclitaxel- eluting stents or coronary artery bypass graft treatment in the Synergy Between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery(SYNTAX) trial[J]. Circulation, 2010,121 (24) : 2645-2653.
  • 9Yu CM, Sanderson JE. Plasma brain natriuretic peptide--an Independent predictor of cardiovascular mortality in acute.heart failure[J]. Eur J Heart Fail, 19 9 9,1 ( 1 ) : 5 9- 6 5.
  • 10Tsutamoto T, Wada A, Maeda K, et al. Attenuation of com- pensation of endogenous cardiac natriuretic peptide system in chronic heart failure: prognostic role of plasma brain natri- uretic peptide concentration in patients with chronic symp- tomatic left ventricular dysfunction[J]. Circulation, 1997, 96(2) :509-516.

同被引文献87

  • 1郭攀,卢长青.B型钠尿肽在心血管疾病诊断及治疗中的价值[J].河南医学研究,2005,14(1):73-76. 被引量:5
  • 2赵昕.B型钠尿肽的生物学特性及在心脏疾病中的应用[J].中国老年学杂志,2006,26(10):1437-1440. 被引量:9
  • 3柯元南,陈纪林.不稳定性心绞痛和非ST段抬高心肌梗死诊断与治疗指南[J].中华心血管病杂志,2007,35(4):295-304. 被引量:2153
  • 4Pokharel Y, Sun W, Polfus LM, etal. Lipoprotein associated hos- pholipase A2 activity, apolipoprotein C3 loss-of-function variants and cardiovascular disease: The Atherosclerosis Risk In Communities Study [J].Atherosclerosis, 2015,241(2) :641-648.
  • 5Gu X, Hou J, Yang S,et al. Is lipoprotein-associated phospho- lipase A2 activity correlated with fibrous-cap thickness and plaque volume in patients with acute coronary syndrome [J]. Coron Artery Dis, 2014, 25(1):10-15.
  • 6Ostadal P, Vondrakova D, Kruger A, et al. Alteration in lipo- protein-associated phospholipase A2 levels during acute coronary syndrome and its relationship to standard biomarkers [J]. Lipids Health Dis,2012, 11:153.
  • 7Holst-Albrechtsen S, Kjaergaard M, Huynh AN, et al. Can lipoprotein-assoeiated phospholipase A2 be used as a predictor of long-term outcome in patients with acute coronary syndrome [J].Curr Cardiol Rev, 2013,9(4) :310-315.
  • 8Xu RX, Zhang Y, Li XL, et al. Relationship between plasma phospholipase A2 concentrations and lipoprotein subfractions in patients with stable coronary artery disease[J]. Clin Chim Acta, 2015, 446:195-200.
  • 9Jabor B, Choi H, Ruel I, et al. Lipoprotein-assoeiated phospho- lipase A(2) (Lp-PLA(2)) in acute coronary syndrome: relation-ship with low-density lipoprotein cholesterol [J].Can J Cardiol, 2013,29(12) :1679-1686.
  • 10Li N, Li S, Yu C, et al. Plasma Lp-PLA2 in acute coronary syndrome: association with major adverse cardiac events in a com- munity-based cohort [J]. Postgrad Med, 2010,122(4) :200-205.

引证文献8

二级引证文献63

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部